Cargando…

Reversible Corpus Callosal Lesions Associated with the Use of Adalimumab for Ulcerative Colitis

Detalles Bibliográficos
Autores principales:	Park, Jin-Woo, Seok, Hung-Yuol, Kim, Yoohwan, Kim, Byung-Jo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Neurological Association 2017
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392469/ https://www.ncbi.nlm.nih.gov/pubmed/28406587 http://dx.doi.org/10.3988/jcn.2017.13.2.209

Ejemplares similares

Surfer's Myelopathy Mimicking Infectious Myelitis
por: Choi, Jongsuk, et al.
Publicado: (2017)

Infliximab versus Adalimumab: Can We Choose the Right One for the Right Patients with Ulcerative Colitis?
por: Park, Sang Hyoung, et al.
Publicado: (2022)

Corpus Callosal Abnormalities in Dogs
por: Gonçalves, R., et al.
Publicado: (2014)

Clinical Features and Associated Abnormalities in Children and Adolescents With Corpus Callosal Anomalies
por: Kim, Young Uhk, et al.
Publicado: (2014)

Infliximab versus Adalimumab, Which One Is Better for Ulcerative Colitis?
por: Kim, Eun Soo
Publicado: (2021)

Corpus callosal microstructure influences intermanual transfer in chimpanzees
por: Phillips, Kimberley A., et al.
Publicado: (2013)

Developmental malformation of the corpus callosum: a review of typical callosal development and examples of developmental disorders with callosal involvement
por: Paul, Lynn K.
Publicado: (2010)

Midsagittal corpus callosal thickness and cognitive impairment in Parkinson's disease
por: Owens‐Walton, Conor, et al.
Publicado: (2022)

Understanding the Role of Adalimumab in the Treatment of Moderately to Severely Active Ulcerative Colitis
por: Kim, Jae Hyun, et al.
Publicado: (2016)

Relapsing Polychondritis and Ulcerative Colitis
por: Almadi, Majid A., et al.
Publicado: (2010)

Unusual polyposis in ulcerative colitis
por: Amarapurkar, Anjali Deepak, et al.
Publicado: (2014)

Arterial ischemic stroke in a patient with co-existence of antiphospholipid syndrome and ulcerative colitis
por: Park, Soonchan, et al.
Publicado: (2022)

Acute Marchiafava-Bignami Disease with Widespread Callosal and Cortical Lesions
por: Kim, Min-Jeong, et al.
Publicado: (2007)

Chronic myelogenous leukemia in ulcerative colitis
por: Katsanos, Konstantinos H., et al.
Publicado: (2011)

Role of EUS in idiopathic ulcerative colitis
por: Rana, Surinder Singh, et al.
Publicado: (2021)

Combination of vedolizumab and immunomodulators in ulcerative colitis
por: Pinton, P
Publicado: (2021)

Spontaneous callosal hemorrhage in a child on continuous ambulatory peritoneal dialysis
por: Gera, D. N., et al.
Publicado: (2016)

A Rare Case Report of a Corpus Callosal Splenial Lesion in the Context of Atypical Neuroleptic Malignant Syndrome
por: Serdenes, Ryan, et al.
Publicado: (2021)

Reply: Careful Assessment Is Needed in Patients with Ulcerative Colitis with Evidence of Cytomegalovirus Reactivation
por: Kim, You Sun, et al.
Publicado: (2015)

Cost-utility analysis of infliximab and adalimumab for refractory ulcerative colitis
por: Xie, Feng, et al.
Publicado: (2009)

Management of difficult-to-treat patients with ulcerative colitis: focus on adalimumab
por: Armuzzi, Alessandro, et al.
Publicado: (2013)

Developments in the treatment of moderate to severe ulcerative colitis: focus on adalimumab
por: Freeman, Hugh J
Publicado: (2013)

Treatment of Recalcitrant Pyoderma Gangrenosum with Ulcerative Colitis by Adalimumab Injection
por: Lee, Jin-Hyup, et al.
Publicado: (2017)

Adalimumab-associated bullous pemphigoid in a patient with ulcerative colitis
por: Wessman, Laurel L., et al.
Publicado: (2017)

A case of periodic fever with corpus callosum agenesis: reverse Shapiro's syndrome
por: Guha, Suparna, et al.
Publicado: (2012)

The role and prospect of tofacitinib in patients with ulcerative colitis
por: Lee, Jun
Publicado: (2023)

Comparison of Long-term Outcomes of Infliximab versus Adalimumab Treatment in Biologic-Naïve Patients with Ulcerative Colitis
por: Lee, Yong Il, et al.
Publicado: (2021)

Letter regarding article ‘Freezing of gait associated with a corpus callosum lesion’
por: Onder, Halil
Publicado: (2016)

Cytotoxic lesion of the corpus callosum as presenting neuroradiological manifestation of COVID-2019 infection
por: Forestier, Géraud, et al.
Publicado: (2020)

Interlimb Transfer of Reach Adaptation Does Not Require an Intact Corpus Callosum: Evidence from Patients with Callosal Lesions and Agenesis
por: Tilsley, Penelope A., et al.
Publicado: (2021)

Microbiome analysis reveals that Ralstonia is responsible for decreased renal function in patients with ulcerative colitis
por: Kim, Jung Min, et al.
Publicado: (2021)

Corpus Callosal Hemorrhage: A Rare Presentation of Extensive Cerebral Venous Thrombosis
por: Ganeshbai, Patel Vishal, et al.
Publicado: (2020)

Reversible lesion in the splenium of the corpus callosum
por: Tetsuka, Syuichi
Publicado: (2019)

Reversible splenial lesion on the corpus callosum in nonfulminant hepatitis A presenting as encephalopathy
por: Ko, Soon Young, et al.
Publicado: (2014)

An indirect comparison of infliximab versus adalimumab or golimumab for active ulcerative colitis
por: Kawalec, Paweł, et al.
Publicado: (2016)

Bullous Pemphigoid Associated with Adalimumab Therapy in a Patient with Ulcerative Colitis
por: Hoffmann, Sebastian, et al.
Publicado: (2018)

Invasive Cryptococcosis and Adalimumab Treatment
por: Horcajada, Juan P., et al.
Publicado: (2007)

Arthritis Associated with Ulcerative Colitis: Our Experience in Palermo
por: Geraci, A, et al.
Publicado: (2009)

Living with ulcerative colitis in Iran: Discovery of psychological problems
por: Mazaheri, Mina, et al.
Publicado: (2019)

The Prognostic Value of Residual Nonrectal Inflammation in Ulcerative Colitis
por: Kang, Eun Ae
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vm69g2c6v41bvh4plhton8oub2